Join a lively discussion of corporate counsel and private practitioners on federal and state regulatory developments impacting the food, drug, biotech, and medical device industries. The FDA Forum is this Section’s longest running annual event, valued by members for offering an insider’s perspective on thorny and emerging regulatory issues. 

Intervenants: James M. Beck

Type d’évènement: Formation juridique continue, Conférence

The MARQ, 250 Marquette Avenue
, Tenant’s Lounge, Suite 200, Minneapolis MN 55401
Date/heure de début
17 April 2024, 1:00 PM CDT
Date/heure de fin
17 April 2024, 6:00 PM CDT
More Information:
Tri-Bar Event

The keynote speaker this year is James Beck, a Senior Policy Analyst at the law firm of Reed Smith and a highly recognized thought leader in life sciences and healthcare related legal issues. Mr. Beck is the founder and co-host of the widely read and influential Drug and Device Law Blog, where he frequently contributes posts on significant legal decisions and other product liability-related issues affecting drug, biotech, and medical device companies. Mr. Beck will speak on the uptick in threats to the FDA’s administrative authority, such as abortion-related challenges to FDA authority over product approvals, the California Food Safety Act, and the anticipated ruling from the U.S. Supreme Court on the future of Chevron deference.

Following Mr. Beck’s presentation are panel discussions among in-house and outside counsel specializing in food law and drug and device law, including panelists from Hershey, Hormel, Post Consumer Brands, Boston Scientific, and Coloplast. Total of 3.5 CLE credits anticipated. We will close the Forum with a social and networking event with light refreshments catered by Surdyk’s.